Month: June 2019
Bristol-Myers lets go of psoriasis drug to save Celgene merger; stock falls
The planned merger between pharmaceutical firms Bristol-Myers Squibb Company (NYSE: BMY) and Celgene (CELG) – touted as a landmark deal…
Earnings preview: Jobs growth to drive Paychex Q4 2019 results
Human resources solution provider Paychex Inc. (NASDAQ: PAYX) is scheduled to report its earnings results for the fourth quarter of…
Earnings preview: Rite Aid unlikely to deliver any surprise in Q1
Rite Aid Corporation (NYSE: RAD) was on the verge of being delisted after the stock price slipped to a record…
DEEP FOCUS: Everything you need to know about GW Pharmaceuticals
Shares of GW Pharmaceuticals (NASDAQ: GWPH) have gained 72% in the year-to-date period, emerging as a new favorite among pot…
BlackBerry reports Q1 earnings on Wednesday
Cybersecurity firm Blackberry (NYSE: BB) is scheduled to report first-quarter 2020 earnings results before the market opens on Wednesday, June…
Earnings preview: Cons outweigh the pros as FedEx gets ready for Q4 report
When FedEx Corporation (NYSE: FDX) reports fourth-quarter report Monday afternoon, after an unimpressive start to the year, it will likely…
Uncertainty looms over T-Mobile-Sprint merger as opposition mounts
The long-pending merger between telecom firms T-Mobile (Nasdaq: TMUS) and Sprint (NYSE: S) suffered a fresh setback this week after…